These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin beta-tigogenin cellobioside (CP-88818; tiqueside). Harwood HJ; Chandler CE; Pellarin LD; Bangerter FW; Wilkins RW; Long CA; Cosgrove PG; Malinow MR; Marzetta CA; Pettini JL J Lipid Res; 1993 Mar; 34(3):377-95. PubMed ID: 8468523 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs. Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512 [TBL] [Abstract][Full Text] [Related]
4. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys. Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144 [TBL] [Abstract][Full Text] [Related]
5. Dose and species dependent pharmacokinetics of a novel sigma receptor antagonist, DuP 734. Kapil RP; Lam GN Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):3-20. PubMed ID: 7620836 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic studies of CP-74,667, a new quinolone, in laboratory animals. Girard D; Gootz TD; McGuirk PR Antimicrob Agents Chemother; 1992 Aug; 36(8):1671-6. PubMed ID: 1329625 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of the acyl coenzyme A:cholesterol acyl transferase inhibitor CP-105,191 in dogs--the effect of food and sesame oil on systemic exposure following oral dosing. Inskeep PB; Davis KM; Reed AE J Pharm Sci; 1995 Feb; 84(2):131-3. PubMed ID: 7738788 [TBL] [Abstract][Full Text] [Related]
8. Absorption, pharmacokinetics and excretion of levovirin in rats, dogs and cynomolgus monkeys. Lin CC; Luu T; Lourenco D; Yeh LT; Lau JY J Antimicrob Chemother; 2003 Jan; 51(1):93-9. PubMed ID: 12493792 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species. Monbaliu J; Verhaeghe T; Willems B; Bode W; Lavrijsen K; Meuldermans W Arzneimittelforschung; 2003; 53(7):486-95. PubMed ID: 12918214 [TBL] [Abstract][Full Text] [Related]
10. Species differences in the pharmacokinetics of recainam, a new anti-arrhythmic drug. Scatina JA; Kimmel HB; Weinstein V; Troy SM; Sisenwine SF; Cayen MN Biopharm Drug Dispos; 1990 Jul; 11(5):445-61. PubMed ID: 2207297 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog. Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917 [TBL] [Abstract][Full Text] [Related]
12. Comparative toxicokinetics of MMB4 DMS in rats, rabbits, dogs, and monkeys following single and repeated intramuscular administration. Hong SP; Gibbs ST; Kobs DJ; Hawk MA; Croutch CR; Osheroff MR; Johnson JD; Burback BL Int J Toxicol; 2013; 32(4 Suppl):38S-48S. PubMed ID: 23929448 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of SCH 56592, a new azole broad-spectrum antifungal agent, in mice, rats, rabbits, dogs, and cynomolgus monkeys. Nomeir AA; Kumari P; Hilbert MJ; Gupta S; Loebenberg D; Cacciapuoti A; Hare R; Miller GH; Lin CC; Cayen MN Antimicrob Agents Chemother; 2000 Mar; 44(3):727-31. PubMed ID: 10681346 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the oral triazole antimycotic vibunazole in animals. Ritter W; Plempel M J Antimicrob Chemother; 1984 Sep; 14(3):243-52. PubMed ID: 6490569 [TBL] [Abstract][Full Text] [Related]
15. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys. Colletti AE; Krieter PA Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272 [TBL] [Abstract][Full Text] [Related]
16. Nonlinear pharmacokinetics of efavirenz (DMP-266), a potent HIV-1 reverse transcriptase inhibitor, in rats and monkeys. Balani SK; Kauffman LR; deLuna FA; Lin JH Drug Metab Dispos; 1999 Jan; 27(1):41-5. PubMed ID: 9884307 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of pseudoephedrine in rats, dogs, monkeys and its pharmacokinetic-pharmacodynamic relationship in a feline model of nasal congestion. Palamanda JR; Mei H; Morrison R; McLeod RL; McCormick K; Corboz M; Xu X; Korfmacher W; Broske L; Nomeir AA Drug Metab Lett; 2010 Apr; 4(2):56-61. PubMed ID: 20446910 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of picumast after administration of 14C-picumast dihydrochloride in dogs, rats, rabbits and monkeys. Schaumann W; Besenfelder E; Boehm E; Neubert P; Roesch A; Sterz H Arzneimittelforschung; 1989 Oct; 39(10A):1321-7. PubMed ID: 2576356 [TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetics of Racivir, (+/-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine in rats, rabbits, dogs, monkeys and HIV-infected humans. Hurwitz SJ; Otto MJ; Schinazi RF Antivir Chem Chemother; 2005; 16(2):117-27. PubMed ID: 15889534 [TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of a thiazole benzenesulfonamide beta 3-adrenergic receptor agonist and its analogs in rats, dogs, and monkeys: improving oral bioavailability. Stearns RA; Miller RR; Tang W; Kwei GY; Tang FS; Mathvink RJ; Naylor EM; Chitty D; Colandrea VJ; Weber AE; Colletti AE; Strauss JR; Keohane CA; Feeney WP; Iliff SA; Chiu SH Drug Metab Dispos; 2002 Jul; 30(7):771-7. PubMed ID: 12065435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]